We were delighted to attend the 16th European ISSX (International Society for the Study of Xenobiotics) and DMDG (Drug Metabolism Discussion Group) Meeting in June! This was the first co-organized meeting for DMDG and ISSX. It provided an extremely valuable opportunity for researchers to gather and exchange ideas and expertise in person in Hertfordshire, United […]
16th European ISSX and DMDG Meeting Read More »
We were pleased to attend the FDA/HESI Roadmap Planning on Hazard and Risk Assessment of Nitrosamine Impurities in Drugs workshop. Organised by the FDA and HESI, this exciting event offered attendees the opportunity to engage in important discussions around the assessment of nitrosamines, including Nitrosamine Drug Substance-related Impurities (NDSRI). Lhasa Principal Scientist, David Ponting presented
Dr. Susanne Stalford, Lhasa Principal Scientist, presented within a Pharmaceutical & BioScience Society workshop, on the topic of Nonclinical Carcinogenicity Studies. The workshop included presentations from regulatory and industry perspectives, on topics relating to carcinogenicity assessment of pharmaceuticals, including: The challenges faced with carcinogenicity assessments, in the development of pharmaceuticals Regulatory and industry perspectives on
Nonclinical Carcinogenicity Studies: Fundamentals, Case Studies and Regulatory Trends Read More »
We thoroughly enjoyed attending Extractables and Leachables USA! This event offered a unique opportunity for E&L industry experts to gather and discuss the latest updates on regulations, best practices, compliance, case studies, biocompatibility, and more. Lhasa Application Scientist, Charlie Modlin presented “Using expert knowledge and machine learning to assess the mutagenicity and skin sensitisation potential
Extractables & Leachables USA Read More »
We were delighted to return to Brasilia to host the Pharmaceutical Industry and Regulators Symposium! Held at the the Auditório do Conselho Federal de Farmácia, this two-day event featured insightful presentations from speakers from both industry and regulators. The Symposium brought together like-minded researchers and regulators, offering attendees a unique opportunity to gain a greater
Pharmaceutical Industry and Regulators Symposium Read More »
We were delighted to attend the Annual Meeting of the GTA; Current Regulatory and Scientific Issues in Genetic Toxicology, at the University of Delaware! Taking place from 3rd to 5th May, this meeting offered an opportunity for scientists from different types of organizations to exchange knowledge, ideas, views and insights concerning the science of genetic
Annual Genetic Toxicology Association Meeting Read More »
Held in Nashville, Tennessee, the SOT 62nd Annual Meeting and ToxExpo featured an array of scientific sessions, posters and presentations. A team of us from Lhasa attended the event, where we hosted two exhibitor-hosted sessions: Tackling ICH S1B using AOPs Supporting drug development using in silico solutions Lhasa Limited scientific posters, in date order. Poster Title: Mechanisms
Society of Toxicology (SOT) 62nd Annual Meeting and ToxExpo Read More »
We were delighted to attend the IPEC Excipients Forum 2023. Lhasa Limited Principal Application Scientist, Grace Kocks presented on the Elemental Impurities Data Sharing Initiative. Held in Lisbon, the IPEC Excipients forum brings together experts on pharmaceutical excipients from across the world.
IPEC Excipients Forum 2023 Read More »
We were delighted to attend the 7th Impurities: Genotoxic, Nitrosamine & Beyond summit in Milan, Italy. In addition to focusing on N-nitrosamines, this event explored detecting and reporting genotoxic impurities, as well as recent advances, further development and future considerations towards the different types of impurities present in drugs. Lhasa Principal Scientist, Michael Burns presented
7th Impurities: Genotoxic, Nitrosamine & Beyond Summit Read More »
We were excited to attend the 11th International Drug Chemistry Congress! Held at the Antalya-Kemer Mirage Park Resort Hotel from March 9th – 12th, this Congress was helpful for all participants in pharmaceutical R&D and production, as well as the international pharmaceutical industry. Principal Application Scientist, Fernanda Waechter presented on nitrosamines and the Complex Nitrosamines data
The 11th International Drug Chemistry Congress Read More »